Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Lympha Press Optimal Plus

K-Number: K182003 · 2019-02-27

Decision Date2019-02-27
Product CodeJOW
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Lympha Press Optimal Plus is a medical device manufactured by Mego Afek AC , Ltd.. It received FDA 510(k) clearance on 2019-02-27 under approval number K182003. The device is classified under product code JOW. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Lympha Press Optimal Plus?

Lympha Press Optimal Plus is a medical device that received FDA 510(k) clearance on 2019-02-27. It is manufactured by Mego Afek AC , Ltd.. The 510(k) number is K182003.

When was Lympha Press Optimal Plus approved by the FDA?

Lympha Press Optimal Plus received FDA 510(k) clearance on 2019-02-27, under approval number K182003.

What company makes Lympha Press Optimal Plus?

Lympha Press Optimal Plus is manufactured by Mego Afek AC , Ltd..

What is the FDA product code for Lympha Press Optimal Plus?

The FDA product code for Lympha Press Optimal Plus is JOW.

Other Devices by Mego Afek AC , Ltd.

View all 7 devices →

Related Devices (Code: JOW)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.